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Polycyclic aromatic hydrocarbons (PAH) such 
as benzo[a]pyrene (BaP) are released to the air 
during incomplete combustion of fossil fuel, 
tobacco, and other organic material (Bostrom 
et al. 2002). In New York City (NYC) and 
other urban areas, traffic and residential 
heating are major sources. Urban, minority 
populations in the United States often have 
disproportionate exposure to air pollution and 
are at greater risk for adverse health and devel-
opmental outcomes (Olden and Poje 1995; 
Perera et al. 2002). Illustrating widespread 
exposure to these pollutants, 100% of the 
mothers in the Columbia Center for Children’s 
Environmental Health (CCCEH) NYC cohort 
had detectable levels of PAH in prenatal per-
sonal air samples. In addition, 40% reported 
environmental tobacco smoke (ETS) exposure 
during pregnancy (Perera et al. 2003).
Because of the heightened susceptibility 
of the fetus and infant, exposures to PAH 
and other environmental pollutants during 
the prenatal and early postnatal stages are 
of particular concern (Anderson et al. 2000; 
Grandjean and Landrigan 2006; National 
Research Council 1993; Perera et al. 2004; 
World Health Organization 1986). In par-
ticular, the prenatal period is thought to be 
highly sensitive to neurotoxic effects of envi-
ronmental contaminants (Nijland et al. 2008; 
Rodier 2004). Laboratory experiments have 
indicated that the fetal brain and nervous 
system may be particularly sensitive to PAH 
(Brown et al. 2007; McCallister et al. 2008; 
Wormley et al. 2004). PAH are transferred 
across the placenta and the fetal blood brain 
barrier [reviewed by Brown et al. (2007)]. 
Following gestational exposure in humans, 
DNA adducts formed by BaP and other 
PAH have been detected in maternal and 
cord blood samples in a range of populations 
(Perera et al. 2005). PAH exposure has also 
been linked to epigenetic effects (Perera et al. 
2009b). In studies in laboratory animals, BaP 
exposure also has been associated with AhR 
(aryl hydrocarbon receptor) up-regulation in 
gestationally exposed rats, suggesting possible 
endocrine disruption (Wu et al. 2003).
In the CCCEH NYC cohort, prenatal 
exposure to PAH has previously been associ-
ated with multiple adverse effects including 
developmental delay at 3 years of age (Perera 
et al. 2006) and reduced IQ at 5 years of age 
(Perera et al. 2009a). Experimental studies 
exposing laboratory animals to PAH dur-
ing the prenatal and neonatal periods have 
reported neurodevelopmental and behavioral 
effects including impairment of memory and 
ability to learn (Brown et al. 2007; Wormley 
et al. 2004), anxiety, and depression-like 
symptoms in the absence of overt toxicologic 
effects (Saunders et al. 2002, 2003, 2006; 
Takeda et al. 2004; Wormley et al. 2004; 
Yokota et al. 2009). Anxiety and depression 
are internalizing problems that can affect 
learning (Emslie 2008; Wood 2006).
We have previously found that a wide 
spectrum of bulky hydrophobic DNA adducts, 
including those formed by PAH, nitro-
PAH, and aromatic amines, detected by the 
32P-postlabeling assay in umbilical cord blood 
from cohort children were associated with 
symptoms of anxiety/depression and atten-
tion problems during childhood (Perera et al. 
2011). Here, in addition to prenatal PAH air 
monitoring, we have used a   chemical-specific 
biomarker of exposure (BaP–DNA adducts) 
to examine the relationship between pre-
natal PAH exposure and child behavior. The 
BaP–DNA adducts are specific to a represen-
tative member of the PAH class and therefore 
more directly complement the prenatal air 
monitoring of BaP and other PAH than the 
32P-radiolabeled adducts, which represent an 
array of pollutants in addition to PAH.
We have examined children’s behavior at 
6–7 years of age in relation to prenatal expo-
sure to PAH and BaP–DNA adducts using the 
Child Behavior Checklist (CBCL) (Achenbach 
and Rescorla 2001). We focused on the syn-
dromes and problems of a priori interest 
(anxiety/depression and attention problems) 
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Ba c k g r o u n d: Airborne polycyclic aromatic hydrocarbons (PAH) are widespread urban air 
  pollutants from fossil fuel burning and other combustion sources. We previously reported that 
a broad spectrum of combustion-related DNA adducts in cord blood was associated with atten-
tion problems at 6–7 years of age in the Columbia Center for Children’s Environmental Health 
(CCCEH) longitudinal cohort study.
oBjectives: We evaluated the relationship between behavioral problems and two different measures 
of prenatal exposure—both specific to PAH  —in the same cohort.
Me t h o d s : Children of nonsmoking African-American and Dominican women in New York City 
(NYC) were followed from in utero to 6–7 years. Prenatal PAH exposure was estimated by personal 
air monitoring of the mothers during pregnancy as well as by the measurement of DNA adducts spe-
cific to benzo[a]pyrene (BaP), a representative PAH, in maternal and cord blood. At 6–7 years of age, 
child behavior was assessed using the Child Behavior Checklist (CBCL) (n = 253). Generalized linear 
models were used to test the association between prenatal PAH exposure and behavioral outcomes.
re s u l t s: In multivariate analyses, high prenatal PAH exposure, whether characterized by personal 
air monitoring (greater than the median of 2.27 ng/m3) or maternal and cord adducts (detectable 
or higher), was positively associated with symptoms of Anxious/Depressed and Attention Problems 
(p ≤ 0.05).
co n c l u s i o n: These results provide additional evidence that environmental levels of PAH encoun-
tered in NYC air can adversely affect child behavior.
key w o r d s : air pollution, child behavior, PAH, prenatal. Environ Health Perspect 120:921–926 
(2012).  http://dx.doi.org/10.1289/ehp.1104315 [Online 14 March 2012]Perera et al.
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based on the experimental findings for PAH 
(Saunders et al. 2002, 2003, 2006; Takeda 
et al. 2004; Wormley et al. 2004; Yokota 
et al. 2009). This is the first report of associa-
tions between child attentional and behavioral 
problems, on the one hand, and two comple-
mentary specific measures of prenatal PAH 
exposure on the other: monitored air concen-
trations of PAH and a PAH-specific biomarker 
of exposure.
Methods
Sample selection. A complete description of 
the NYC cohort and study design appears 
elsewhere (Perera et al. 2003, 2006). Briefly, 
African-American and Dominican women 
who resided in Washington Heights, Harlem, 
or the South Bronx in New York City (USA) 
were recruited between 1998 and 2003 
through the local prenatal care clinics into 
a prospective cohort study. To reduce the 
potential for confounding, enrollment was 
restricted to women who were nonactive 
cigarette smokers in the age range of 18–35 
years; nonusers of other tobacco products or 
illicit drugs; free of diabetes, hypertension, 
or known HIV; and had initiated prenatal 
care by the 20th week of pregnancy. Postnatal 
interviews were administered to the mothers 
in person when the child was 6 months of age 
and annually thereafter to determine changes 
in children’s health, residence, and ETS 
exposure. Developmental status was assessed 
every 1–2 years. The Institutional Review 
Board of the New York Presbyterian Medical 
Center approved the study; the mothers pro-
vided informed consent for themselves and 
their children < 7 years of age, and children 
≥ 7 years provided assent.
A total of 617 mother–child pairs had 
complete prenatal PAH monitoring and pre-
natal questionnaire data. By the time of this 
analysis, 431 children had reached 7 years of 
age, and 294 children had the CBCL com-
pleted at age 6–7. The sample included in 
the present analysis was composed of 253 of 
those children who also had available data on 
explanatory or potential confounding vari-
ables of interest. Table 1 compares character-
istics of this sample with those subjects who 
were not included due to missing covariates 
or CBCL data (n = 364). The two groups 
were similar with respect to level of PAH and 
ETS exposure, gestational age, maternal edu-
cation, and maternal demoralization, as mea-
sured by the PERI (Psychiatric Epidemiology 
Research Interview) Demoralization Scale 
(Dohrenwend et al. 1978); however, they 
differed with respect to the home caretak-
ing environment as measured by the HOME 
(Home Observation for Measurement of 
the Environment) Inventory (Bradley 1994) 
(p = 0.03), sex of the child (p = 0.05), and 
ethnicity (p < 0.0001). Specifically, the group 
included in the analysis had a higher pro-
portion of girls and African Americans and a 
more favorable home environment.
Personal interview. A 45-min question-
naire was administered by a trained bilingual 
interviewer during the last trimester of preg-
nancy to obtain demographic information, 
residential history, and health and environ-
mental data such as active smoking (to con-
firm nonactive smoking status) and passive 
smoking. In this cohort, self-reported expo-
sure to ETS was correlated with cotinine mea-
sured in cord blood (r = 0.44, p < 0.0001). 
The questionnaire also elicited information on 
dietary PAH (consumption of broiled, fried, 
grilled, or smoked meat) and socioeconomic 
information related to income and educa-
tion (Perera et al. 2003). Postnatal interviews 
were administered in person when the child 
was 6 months old and annually thereafter to 
determine changes in residence, exposure to 
ETS, and health and environmental condi-
tions. The quality of the proximal caretak-
ing environment was assessed at child’s age 
3 years using Caldwell and Bradley’s HOME 
Inventory (Bradley 1994).
Prenatal personal PAH assessment. 
Personal monitoring was carried out during 
the third trimester of pregnancy as previ-
ously described (Perera et al. 2003). Vapors 
and particles of ≤ 2.5 µm in diameter were 
collected on a precleaned quartz microfiber 
filter and a precleaned polyurethane foam 
(PUF) cartridge backup (University Research 
Glassware, Chapel Hill, NC). The samples 
were analyzed at Southwest Research Institute 
(SWRI) for BaP, benz[a]anthracene, chrysene, 
benzo[b]fluroanthene, benzo[k]fluroanthene, 
indeno[1,2,3-cd]pyrene, dibenz[a,h]anthra-
cene, and benzo[g,h,i]perylene. For quality 
control (QC), each personal monitoring result 
was assessed for accuracy in flow rate, time, 
and completeness of documentation. Samples 
not meeting QC criteria for adequacy were 
not included in the analysis.
We validated 48-hr personal monitor-
ing as an indicator of longer-term, integrated 
exposure in two ways. In a subset of the NYC 
cohort (n = 84), indoor air was monitored over 
6 weeks during the third trimester concurrent 
with the personal air monitoring: The prenatal 
personal air concentrations were significantly 
correlated with indoor levels of PAH (sum 
of the 8 PAH) (r = 0.58, p‑value < 0.001) 
(Rundle et al. 2012). In addition, among a 
subset of pregnant women (n = 80) participat-
ing in a parallel birth cohort study in Poland 
and simultaneously monitored for personal, 
indoor, and outdoor airborne PAH, all three 
measurements were found to be highly cor-
related (pair-wise Spearman’s coefficients 
≥ 0.84, p < 0.01) (Choi et al. 2008), support-
ing the use of personal monitoring to inte-
grate indoor and outdoor exposure. A caveat 
is that the air concentrations of PAH in the 
Polish study were 10 times higher than in the 
NYC cohort (Jedrychowski et al. 2005).
Biomarkers. Adducts in white blood 
cells reflect individual variation in exposure, 
absorption, metabolic activation, and DNA 
repair, providing a biological dosimeter and 
marker of potential risk. We collected umbili-
cal cord blood at delivery and maternal blood 
(30–35 mL) generally on the first day after 
delivery and transported the samples to the 
CCCEH Molecular Epidemiology Laboratory 
within several hours of collection. The buffy 
coat, packed red blood cells, and plasma were 
separated and stored at –70°C. BaP–DNA 
adducts in extracted white blood cell DNA 
were analyzed using the high performance 
liquid chromatography (HPLC)/fluorescence 
method of Alexandrov et al. (1992), which 
detects BaP tetraols. The method has been 
described previously (Perera et al. 2004).
Behavioral outcomes. The CBCL is a 
widely used instrument shown to be sensi-
tive to diverse prenatal environmental 
exposures, including stress events, smoking 
during pregnancy, and exposure to various 
pollutants (Axtell et al. 2000; Rauh et al. 
2006; Robinson et al. 2008; Wasserman 
Table 1. Characteristics of sample.
Subjects in the analysis 
(n = 253)
Subjects not includeda 
(n = 364)
Variable Mean ± SD or % n Mean ± SD or %
PAH (ng/m3) 3.23 ± 2.76 364 3.13 ± 4.10
Prenatal ETS exposure (% yes) 37.55 364 32.14
Percent femaleb 56.52 364 48.35
Gestational age (weeks) 39.51 ± 1.57 364 39.59 ± 1.35
Maternal demoralization scorec 1.15 ± 0.62 324 1.15 ± 0.65
Maternal education (years) 11.80 ± 2.04 364 11.85 ± 2.31
Maternal TONI-2 scored 20.87 ± 8.96 232 20.57 ± 8.62
Home environmentb,e  39.87 ± 5.66 215 38.60 ± 6.82
Ethnicity (% African American)b,f  49.04 364 30.22
Heating season (% yes)g 56.92 362 58.01
Change of residence before the age of testing 64.03 67 64.18
aSome subjects were not included due to missing CBCL or information on at least one covariate. bSignificantly different 
between the two groups based on Pearson’s chi-square test. cMaternal demoralization during pregnancy. dNonverbal 
intelligence measured by the TONI-2. eHOME Inventory as a measure of the home caretaking environment. fPercent 
African American; the rest are Dominican. gThird trimester in heating season. Prenatal exposure to airborne PAH and child behavior
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et al. 2001). Research workers trained in 
neurodevelopmental testing administered the 
118-item CBCL for children 6–18 years of 
age (Achenbach and Rescorla 2001) to the 
mothers in English or Spanish. Specifically, 
the mothers completed the CBCL with guid-
ance as needed from the research workers. 
The syndrome scores were computed for the 
two a priori domains of interest (Anxious/
Depressed and Attention Problems) by sum-
ming the scores on the specific items, yield-
ing a continuous raw score. The raw scores 
were also converted to standardized T-scores, 
generated according to the procedure of 
Abramowitz and Stegun (1968). The T-score 
is truncated (Petersen et al. 1989): A score 
of 50 is assigned to those with percentiles of 
raw scores ≤ 50 based on a reference popula-
tion (Achenbach and Rescorla 2001), whereas 
children with raw score percentiles > 50 are 
assigned an actual T-score.
The CBCL also yields scales derived 
from the Diagnostic and Statistical Manual of 
Mental Disorders, 4th ed. (DSM-IV; American 
Psychiatric Association 2000) that are 
intended to approximate clinical   diagnoses. 
The DSM-IV scores are dichotomized using 
a borderline or clinical cut point correspond-
ing to the 93rd percentile in a reference 
population for each domain (Achenbach and 
Rescorla 2001). Children were thus classified 
as in the borderline or clinical range (T‑score 
≥ 65) or in the normal range (T‑score < 65) 
for the DSM-IV–oriented Anxiety Problems 
and for Attention Deficit/Hyperactivity 
Problems.
Because maternal intelligence is a known 
predictor of child neurodevelopment across 
populations, the Test of Nonverbal Intelligence, 
2nd ed. (TONI-2) (Brown et al. 1990) was 
administered to the mothers when the child 
was about 3 years of age. The TONI-2 is a 
15-min, language-free measure of general 
intelligence, relatively stable and free of cul-
tural bias. The quality of the proximal caretak-
ing environment is also a predictor of child 
neurodevelopment, so Caldwell and Bradley’s 
HOME Inventory (Bradley 1994) was admin-
istered at about 3 years to assess physical and 
interactive home characteristics. Because ambi-
ent PAH concentrations are higher in the win-
ter months (heating season), we adjusted for 
season of monitoring (heating vs. nonheating 
season).
Statistical analysis. As in prior analyses 
(Perera et al. 2003), a composite PAH variable 
was computed as the sum of the eight intercor-
related PAH air concentration measures (r-val-
ues ranging from 0.38–0.96; all p < 0.001 
by Pearson’s correlation). This variable was 
dichotomized at the median for the parent 
population (2.273 ng/m3) to obtain a measure 
of high/low exposure. In separate analyses, 
PAH were log transformed and treated as a 
continuous variable. BaP–DNA adduct data 
were available for 223 maternal samples and 
148 cord blood samples. Adduct levels were 
dichotomized as detectable/nondetectable, 
with detectable levels found in 87 maternal 
and 56 cord blood samples.
Covariates were selected based on whether 
they were significant contributors to the model 
(at p ≤ 0.1) for at least one of the outcomes. 
They included maternal self-report of ETS 
exposure during pregnancy, sex of child, ges-
tational age of the child, mother’s intelligence, 
mother’s completed years of education before 
birth of the child, maternal prenatal demor-
alization, child’s age at assessment, the qual-
ity of the early home caretaking environment 
assessed when the child was around 3 years of 
age, and season at time of monitoring (heating 
vs. nonheating) (Table 1). Dietary PAH was 
not a predictor of outcomes at a p ≤ 0.1 and 
was not included in the model. Gestational 
age was based on medical record data for 
almost all subjects. To adjust for postnatal 
exposure to PAH, further analyses included 
change of residence before the age of testing as 
a proxy for possible change in PAH exposure 
or PAH metabolites measured in child urine 
collected at 3 years of age. We also adjusted 
for maternal reported postnatal ETS expo-
sure before the age of testing. Correlations 
between continuous airborne PAH and ETS 
and dietary PAH, respectively, were not signif-
icant using Spearman rank-order correlation 
and Pearson correlation (r = –0.01, p = 0.82 
and r = 0.09, p = 0.18, respectively; n = 238 
for both). The correlation between PAH and 
cord lead levels, measured at the Centers for 
Disease Control and Prevention (CDC) using 
inductively coupled plasma mass spectrometry 
(CDC/Division of Laboratory Science 2003), 
was not significant using Pearson correlation 
(r = –0.01, p = 0.77, n = 168) in the limited 
subset with both measurements.
We used continuous raw scores and 
dichotomized T-scores in the analyses of 
the CBCL syndrome scores. We applied the 
Poisson model on the raw syndrome scores 
as they are counts data with a right skew. 
The syndrome T-scores were dichotomized at 
65 (the cutoff for the borderline and clinical 
range) (Achenbach and Rescorla 2001) and 
analyzed using a logistic model. Similarly, we 
used logistic regression to analyze the dichoto-
mized DSM-IV–oriented Anxiety Problems 
and Attention Deficit/Hyperactivity Problems.
This analysis involved multiple compari-
sons. Although the Bonferroni method can 
be overly conservative (Westfall and Young 
1993), we report both the uncorrected and 
corrected p‑values. The Bonferroni-adjusted 
significance level was α = 0.05/6 = 0.0083 
(six outcomes tested).
Results
Using personal air monitoring data as the 
exposure measure. Table 2 provides the distri-
bution of CBCL scores, while Table 3 shows 
the distribution of children in the normal and 
borderline or clinical range for logistic models. 
In simple Poisson regression (without adjust-
ment for covariates), the children of women 
with higher monitored prenatal exposure to 
PAH had significantly higher scores, and thus 
more symptoms of Anxious/Depressed and 
Attention Problems at 6–7 years than did 
children with lower prenatal PAH exposure. 
In the full Poisson model after adjusting for 
possible confounders, higher monitored PAH 
exposure was associated with a significantly 
higher symptom score of Anxious/Depressed 
(1.45 times that of the low PAH exposure 
group, 95% confidence interval (CI): 1.22, 
Table 2. Distribution of outcomes in n = 253 children with PAH measurements.
Outcome
Score range Mean of scores Percent in borderline 
or clinical rangeb T-scorea Raw score T-score Raw score
Anxious/depressed 50–82 0–17 55.54 2.55 6.32
Attention problems 50–83 0–16 56.19 3.34 6.72
Anxiety problems (DSM-IV) 0–9 1.53 9.48
Attention deficit/hyperactivity problems (DSM-IV) 0–14 3.28 7.91
aThe T-score is truncated (Petersen et al. 1989); that is, a score of 50 is assigned to those with percentiles of raw scores 
≤ 50 based on a reference population (Achenbach and Rescorla 2001). bThe syndrome T-scores were dichotomized at 65 
as the cutoff for the borderline and clinical range; the DSM-IV–oriented Anxiety Problems scale was also dichotomized at 
93rd percentile. 
Table 3. Distribution of dichotomized CBCL outcomes for logistic models.
Anxious/depressed Attention problems
DSM-IV Anxiety 
Problems
DSM-IV Attention 
Deficit/Hyperactivity 
Problems
Normal 
range
Borderline 
or clinical
Normal 
range
Borderline 
or clinical
Normal 
range
Borderline 
or clinical
Normal 
range
Borderline 
or clinical Total
PAH 237 16a 236 17 229 24 233 20 253
Maternal adducts 212 11 208 15 204 19 205 18 223
Cord adducts 136 12 137 11a 130 18 137 11 148
aFewer than 5 children were in the borderline or clinical range in the low-exposure group, making these results less 
reliable.Perera et al.
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1.72; p < 0.0001) and with the symptom 
score of Attention Problems (1.28 times that 
of the low PAH exposure group; 95% CI: 
1.10, 1.48; p = 0.001, after adjustment using 
the Bonferroni method) (Table 4).
In logistic regression on the syndrome 
scales, higher PAH exposure was significantly 
associated with both Anxious/Depressed and 
Attention Problems (Table 4). However, 
because < 5 children were in the borderline 
or clinical range in the low-exposure group 
for Anxious/Depressed, these results are 
less reliable.
In logistic regression after adjustment, 
higher PAH exposure was associated with 
higher odds of DSM-IV–oriented Anxiety 
Problems [odds ratio (OR) = 4.59; 95% CI: 
1.46, 14.27; p‑value = 0.009] (Table 4). In 
contrast, high PAH exposure was not sig-
nificantly associated with DSM-IV–oriented 
Attention Deficit/Hyperactivity Problems 
(OR = 2.30; 95% CI: 0.79, 6.70).
In separate models with log-transformed 
continuous PAH as the independent vari-
able, monitored PAH exposure was posi-
tively associated with the syndrome score of 
Anxious/Depressed (1.20 times that of the 
low PAH exposure group; 95% CI: 1.06, 
1.37; p = 0.004). Log-transformed PAH expo-
sure was also positively associated with DSM-
IV–oriented anxiety (OR = 2.03 for a 1-unit 
increase in log PAH; 95% CI: 0.97, 4.26; 
p = 0.060) and with Attention Problems (OR 
= 1.54; 95% CI: 0.70, 3.40; p = 0.283).
Prenatal ETS was a significant predictor of 
Anxious/Depressed and Attention Problems at 
6–8 years of age. Maternal prenatal demoral-
ization was also a significant predictor of most 
of the outcomes evaluated. Using change of 
residence before the age of testing as a proxy 
for variation in PAH exposure between the 
pre- and postnatal periods, the significance of 
the associations between higher prenatal PAH 
and outcomes was materially unchanged, 
both for symptoms of Anxious/Depressed 
(1.45 times that of the low PAH exposure 
group; 95% CI: 1.22, 1.72; p < 0.0001) and 
for DSM-IV–oriented Anxiety Problems 
(OR = 4.36; 95% CI: 1.41, 13.44; p = 0.011). 
The same was true for Attention Problems 
(1.27 times that of the low PAH exposure 
group; 95% CI: 1.10, 1.47; p = 0.001). After 
controlling for urinary PAH metabolites at 3 
years of age in the subset with available bio-
marker data (n = 191), the association between 
prenatal PAH and syndrome scores became 
stronger (Anxious/Depressed: 1.72 times that 
of the low PAH exposure group; 95% CI: 
1.40, 2.10; p = < 0.0001; Attention Problems: 
1.38 times that of the low PAH exposure 
group; 95% CI: 1.16, 1.64; p = 0.0002) [see 
Supplemental Material, Table 4 (http://dx.doi.
org/10.1289/ehp.1104315)]. Controlling for 
postnatal exposure to ETS before age of test-
ing did not materially influence the results 
(data not shown).
In separate analyses, we adjusted for ETS 
exposure using log-transformed cord coti-
nine as a continuous variable in a subset of 
the sample with available data (n = 194). 
Associations with PAH were similar to 
those adjusted for self-reported ETS expo-
sure (Anxious/Depressed: 1.40 times that of 
the low PAH exposure group; 95% CI: 1.15, 
1.71; p = 0.001; Attention Problems: 1.24 
times that of the low PAH exposure group; 
95% CI: 1.04, 1.47; p = 0.016). The odds 
ratio for DSM-IV–oriented Anxiety Problems 
was closer to the null, though still positive 
(OR = 2.9; 95% CI: 0.81, 10.43; p = 0.1); this 
may be attributable to reduced sample size.
In separate models, we further controlled 
for other neurotoxic environmental exposures 
measured in the CCCEH cohort including 
bisphenol A (BPA), the pesticide chlorpyrifos, 
and phthalates using a summary score for the 
number of these coexposures that were above 
the median level for the cohort. The asso-
ciations between PAH and CBCL Anxious/
Depressed and Attention Problems syndrome 
scores remained similar when adjusting for 
the summary scores of these other pollut-
ants; however, the sample size was reduced to 
n = 110 (Anxious/Depressed: 1.63 times that 
of the low PAH exposure group; 95% CI: 
1.22, 2.17; p = 0.001; Attention Problems: 
1.54 times that of the low PAH exposure 
group; 95% CI: 1.22, 1.94; p = 0.0002; 
DSM-IV–oriented Anxiety Problems: 
OR = 7.19; 95% CI: 0.88, 58.48; p = 0.065; 
DSM-IV–oriented ADHD Problems: 
OR = 4.77; 95% CI: 0.74, 30.58; p = 0.100). 
The summary score was not a significant inde-
pendent predictor of any of the outcomes.
Using PAH (BaP)–DNA adducts as the 
exposure measure. We analyzed the relation-
ship between cord and maternal BaP–DNA 
adducts and CBCL outcomes, using the same 
approach as for monitored PAH, with adjust-
ment for the same covariates.
As shown in Table 4, in the Poisson model 
detectable levels of PAH adducts in both 
maternal blood and cord blood were associ-
ated with significantly higher scores on the 
CBCL syndromes of Anxious/Depressed (1.23 
times that of the nondetectable adducts group; 
95% CI: 1.04, 1.46; p = 0.019 for maternal; 
Table 4. Associations between all measures (PAH exposure, maternal and cord PAH (BaP)–DNA adducts measured via HPLC, and cord PAH (BaP)–DNA 
adducts measured via 32P) and CBCL Syndrome and DSM Oriented outcomes in children ages 6–7 years.a
Syndrome scale  
Anxious/Depressed
Syndrome scale  
Attention Problems
Poisson Raw Logistic dichotomized T Poisson Raw Logistic dichotomized T
Exposure
Exp 
beta 95% CI p-Value OR 95% CI p-Value
Exp 
beta 95% CI p-Value OR 95% CI p-Value
PAH (high/low) (n = 253, n = 16) 1.45 (1.22, 1.72) < 0.0001 8.89 (1.70, 46.51) 0.010b 1.28 (1.10, 1.48) 0.001 3.79 (1.14, 12.66) 0.030
Maternal HPLC adductsc (n = 223) 1.23 (1.04, 1.46) 0.019 1.42 (0.38, 5.35) 0.603 1.25 (1.08, 1.45) 0.003 2.24 (0.74, 6.77) 0.153
Cord HPLC adductsc (n = 148) 1.46 (1.19, 1.78) < 0.001 2.56 (0.69, 9.43) 0.159 1.32 (1.11, 1.58) 0.002 4.06 (0.99, 16.63) 0.051b
Cord 32P adductsd,e (n = 205) –0.03 (–0.22, 0.16) 0.773 1.42 (0.45, 4.46) 0.544 0.22 (0.06, 0.38) 0.009 3.30 (1.22, 12.54) 0.022
DSM-IV–oriented scale 
Anxiety Problems
DSM-IV–oriented scale 
Attention Deficit/Hyperactivity Problems
Logistic model Logistic model
Exposure OR 95% CI p-Value OR 95% CI p-Value
PAH (high/low) (n = 253) 4.59 (1.46, 14.27) 0.009 2.30 (0.79, 6.70) 0.129
Maternal HPLC adductsc (n = 223) 2.19 (0.79, 6.07) 0.133 1.84 (0.66, 5.12) 0.243
Cord HPLC adductsc (n = 148) 2.53 (0.84, 7.65) 0.100 2.64 (0.68, 10.26) 0.161
Cord 32P adductse,f (n = 205) 1.26 (0.42, 3.82) 0.683
aCovariates in the models include prenatal ETS, sex of child, gestational age, maternal IQ, HOME inventory, maternal education, ethnicity, prenatal demoralization, age at assessment, 
and heating season. bThese categories had < 5 children in each category, so these results are less reliable. cHPLC adduct levels dichotomized at the detection level (detectable/
not detectable), with detection occurring in n = 87 maternal and n = 56 cord blood samples. d32P adducts were dichotomized at upper quartile, with 149 children classified as “low” 
exposure and 56 children classified as “high” exposure. eThese results were published previously (Perera et al. 2011). fThe earlier publication (Perera et al. 2011) did not analyze 
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and 1.46 times that of the nondetectable 
adducts group; 95% CI: 1.19, 1.78; p < 0.001 
for cord). The same was true for Attention 
Problems (1.25 times that of the nondetectable 
adducts group; 95% CI: 1.08, 1.45; p = 0.003 
for maternal; and 1.32 times that of the non-
detectable adducts group; 95% CI: 1.11, 1.58; 
p = 0.002 for cord). Thus, the two measures 
(personal monitoring and PAH (BaP)-specific 
DNA adducts) gave similar results for the 
CBCL symptom scores in the Poisson model. 
In logistic regression on the dichotomized 
syndrome scales, although detectable levels of 
cord adducts were associated with Attention 
Problems, < 5 children were in the borderline 
or clinical range in the low-exposure group, 
making these results less reliable.
Similar to monitored PAH, cord and 
maternal adducts were not associated with 
DSM-IV–oriented Attention Deficit/
Hyperactivity Problems. In contrast to moni-
tored PAH, logistic regression did not show 
significant associations between BaP–DNA 
adducts in either maternal or cord blood with 
DSM-IV–oriented Anxiety Problems. The 
results were materially unchanged following 
adjustment for postnatal exposures to PAH 
or ETS. Parameter estimates and CIs for all 
variables included in final models for ambient 
PAH, maternal adducts, and cord adducts 
are provided in Supplemental Material 
Tables 1, 2, and 3 respectively (http://dx.doi.
org/10.1289/ehp.1104315). 
Discussion
This is the first report of an association between 
child behavioral problems and two comple-
mentary measures specific to pre  natal PAH 
exposure: prenatally monitored air concen-
trations of PAH and a PAH-specific bio-
marker of exposure (BaP–DNA adducts) in 
cord blood. The finding of significant asso-
ciations between two complementary measures 
of prenatal exposure to PAH and indicators 
of both Anxious/Depressed and Attention 
Problems in children is consistent with prior 
experimental research and with our previous 
reports indicating that fetal exposure to PAH 
is associated with impaired cognitive develop-
ment of children in the cohort (Perera et al. 
2006, 2009a). However, the results with the 
PAH (BaP)–specific adducts measured here 
by HPLC in cord and maternal blood differ 
somewhat from those reported by us previ-
ously using a broader spectrum of adducts 
measured in cord blood by 32P-postlabeling 
(Perera et al. 2011). Although the associations 
with symptoms of attention problems were 
similar using all three measures (monitored 
PAH and the two different types of adducts), 
the broader spectrum of adducts measured by 
32P-postlabeling was not significantly associ-
ated with symptoms of anxiety/depression at 
7 years of age; it was, however, significantly 
and positively associated with symptoms of 
anxiety/  depression at 5 years. This divergence is 
not unexpected given that the 32P-postlabeling 
method detects adducts formed by a range of 
hydrophobic aromatic hydrocarbons in addi-
tion to PAH, such as nitro-aromatic com-
pounds (e.g., 3-nitro  benzanthrone) (Arlt et al. 
2001) and heterocyclic amines (e.g., 4-amin-
obiphenyl) (Munnia et al. 2007). In contrast, 
the HPLC method detects the adducts formed 
by BaP. BaP is considered a representative 
PAH and in our study was highly correlated 
with the other 7 genotoxic PAH measured in 
prenatal air (r = 0.80–0.96, p = 0.001 except 
for dibenz[a,h]anthracene, r = 0.53, p < 0.001).
Although in the logistic model only moni-
tored PAH was significantly associated with 
DSM-IV–oriented Anxiety Problems, most of 
the other associations between symptom scores 
and measured PAH are consistent. It is likely 
that PAH are operating through mechanisms 
in addition to direct genotoxicity evidenced 
by DNA adduct formation. In fact, a number 
of pathways have been suggested including 
endocrine disruption (Archibong et al. 2002; 
Bui et al. 1986; Takeda et al. 2004), bind-
ing to receptors for placental growth factors 
resulting in decreased exchange of oxygen and 
nutrients (Dejmek et al. 2000), binding to the 
human Ah receptor to induce P450 enzymes 
(Manchester et al. 1987), DNA damage result-
ing in activation of apoptotic pathways (Meyn 
1995; Nicol et al. 1995; Wood and Youle 
1995), oxidative stress due to inhibition of the 
brain antioxidant scavenging system (Saunders 
et al. 2006), or epigenetic alterations affecting 
gene expression (Perera and Herbstman 2011; 
Wilson and Jones 1983). Fetal BaP exposure 
also influenced the expression of nuclear tran-
scription factors that mediate the onset of 
neuronal cell differentiation, suggesting that 
there may be widespread effects of this agent 
in the developing brain, ultimately contribut-
ing to neurobehavioral impairment (Hood 
et al. 2000). Although the exposures/doses 
in the animal studies are higher than those 
in the NYC cohort, a number of laboratory 
studies have observed depression-like symp-
toms and impaired memory in experimental 
animals exposed gestationally to PAH at doses 
below those causing overt toxicologic effects 
(Saunders et al. 2002; Wormley et al. 2004).
The children in the CCCEH cohort are 
being followed to 12 years of age; therefore 
subsequent testing will provide a picture of 
the longer-term developmental outcomes of 
children in the cohort. The strengths of the 
study include the fact that we were able to 
account for a number of factors other than 
PAH exposure that are known to affect child 
neurobehavioral  development,  drawing 
on individual prenatal exposure data from 
personal monitoring, biomarker data, and 
extensive medical record and questionnaire 
data. We were also able to confirm our find-
ings from prenatal PAH monitoring using 
BaP–DNA adducts as our dosimeter.
We acknowledge a number of limitations of 
this epidemiologic study. First, unmeasured fac-
tors such as other pollutants and stress may have 
contributed to residual confounding. Further, a 
single 48-hr prenatal monitoring during the 
second or third trimester was used as a basis for 
estimating exposure. However, this single per-
sonal air measurement has been associated with 
adverse health and developmental outcomes in 
two cohorts (Choi et al. 2006; Edwards et al. 
2010; Perera et al. 2003, 2006, 2009a) and has 
been correlated with indoor PAH concentra-
tions monitored over a 6-week period as well as 
with indoor and outdoor PAH concentrations 
monitored during the same 48-hr time period 
(Rundle et al. 2012). We therefore consider 
the single monitoring time point to be a useful 
indicator of prenatal exposure to PAH via inha-
lation. In addition, other studies have found 
that ETS exposure has been associated with 
behavioral problems (Fergusson et al. 1993; 
Weitzman et al. 1992). Although we have 
adjusted for the possible confounding effects 
of ETS, there is always the possibility that some 
residual confounding remains, possibly due 
to measurement error or the shared variance 
between ETS and PAH measures. Because cord 
blood cotinine was available only for a subset of 
participants, we used self-reported ETS expo-
sure as a measure of passive smoking. However, 
in the smaller sample with cotinine measure-
ments in cord blood, results were similar. 
Finally, children born severely preterm would 
not have been included in our analysis because 
PAH monitoring was carried out in the third 
trimester, and we excluded active smokers, illicit 
drug users, and women with preexisting disease. 
Our findings may therefore not be generalizable 
to more at-risk populations.
Conclusion
This study provides evidence that pre  natal 
exposure to environmental PAH at levels 
encountered in the air of New York City 
may influence child behavior. The results 
suggest an adverse impact of prenatal PAH 
exposure on child behavior that could impact 
cognitive development and ability to learn. 
Anxiety, depression, and attention problems, 
which were associated with PAH exposure 
and BaP–DNA adducts in our study popula-
tion, have been shown to affect subsequent 
academic performance (Emslie 2008; Wood 
2006). PAH are widespread in urban envi-
ronments worldwide largely as a result of 
fossil fuel combustion. Fortunately, it is pos-
sible to reduce airborne PAH concentrations 
using currently available pollution controls, 
greater energy efficiency, the use of alternative 
energy sources, and regulatory intervention to 
remove highly polluting sources.Perera et al.
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